MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3960/jslrt.25010

Медицинская библиотека · Journal of clinical and experimental hematopathology : JCEH · 2025

The outcome of patients with peripheral T cell lymphoma treated with doxorubicin-based (CHOP) and pirarubicin-based regimen (THP-COP) regimen: a single institution experience.

Iriyama Noriyoshi, Miura Katsuhiro, Takahashi Hiromichi, Nakagawa Masaru, Iizuka Kazuhide, Otake Shimon, Hamada Takashi, Koike Takashi, Kurihara Kazuya, Endo Toshihide, Nakamura Hideki

СтатьяПеревод в очереди

Аннотация

This study investigates the outcomes of patients with peripheral T-cell lymphoma (PTCL) treated with a doxorubicin-based regimen (CHOP) and a pirarubicin-based regimen (THP-COP). Newly diagnosed patients with PTCL between 2001 and 2021 were classified by initial treatment, either CHOP or THP-COP regimen. The treatment response, event-free survival (EFS), and overall survival (OS) were assessed. Overall, 65 patients were analyzed, with 41 classified into the CHOP group and 24 into the THP-COP group. Dose-intensified regimen was applied in 22 patients (53.7%) in the CHOP group and 16 (66.7%) in the THP-COP group. When stratified by treatment, the complete response (CR) rates in the CHOP group and the THP-COP group were 66% and 46% (P = 0.273), the 3-year EFS rates were 52.1% and 29.2% (P = 0.0492), and the 3-year OS rates were 72.7% and 48.6% (P = 0.0718), respectively. When stratified by treatment intensity, the CR rates in the dose-intensified group and the conventional dose group were 65% and 50% (P = 0.230), the 3-year EFS rates were 45.9% and 39.6% (P = 0.995), and the 3-year OS rates were 61.1% and 66.4% (P = 0.267), respectively. This study revealed no significant advantage of the THP-COP regimen over the CHOP regimen regarding treatment outcomes for newly diagnosed PTCLs.

Для цитирования: Iriyama Noriyoshi, Miura Katsuhiro, Takahashi Hiromichi, Nakagawa Masaru, Iizuka Kazuhide, Otake Shimon, Hamada Takashi, Koike Takashi, Kurihara Kazuya, Endo Toshihide, Nakamura Hideki. The outcome of patients with peripheral T cell lymphoma treated with doxorubicin-based (CHOP) and pirarubicin-based regimen (THP-COP) regimen: a single institution experience.. Journal of clinical and experimental hematopathology : JCEH. 2025. DOI: 10.3960/jslrt.25010.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.